Aktuellt
SENASTE
SpagoPix (earlier SN132D, now pegfosimer manganese) was compared with ultrasound and traditional MRI among patients with suspected endometriosis. This open phase 2a study included up to 18 patients. The top-line results support the primary endpoint as the treating gynaecologist discovered most endometriosis lesions when using pegfosimer manganese as a contrast agent.
LÄS MER
